4//SEC Filing
VAN BEEK JEROEN B 4
Accession 0000899243-22-029045
CIK 0001754068other
Filed
Aug 16, 8:00 PM ET
Accepted
Aug 17, 5:58 PM ET
Size
7.2 KB
Accession
0000899243-22-029045
Insider Transaction Report
Form 4
Allovir, Inc.ALVR
VAN BEEK JEROEN B
Chief Commercial Officer
Transactions
- Sale
Common Stock
2022-08-16$8.30/sh−15,590$129,473→ 386,363 total - Award
Common Stock
2022-08-16+15,000→ 401,363 total
Footnotes (3)
- [F1]Represents shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units ("RSUs"), and does not represent a discretionary trade by the Reporting Person.
- [F2]The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $8.12 to $8.51. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.
- [F3]The shares reported in this transaction represent RSUs issued under the AlloVir, Inc. 2020 Stock Option and Grant Plan (the "Plan"). Each RSU represents the contingent right to receive one share of the Issuer's Common Stock. 25% of the RSUs shall vest on August 16, 2023, with the remainder vesting in twelve equal quarterly installments thereafter.
Documents
Issuer
Allovir, Inc.
CIK 0001754068
Entity typeother
Related Parties
1- filerCIK 0001743662
Filing Metadata
- Form type
- 4
- Filed
- Aug 16, 8:00 PM ET
- Accepted
- Aug 17, 5:58 PM ET
- Size
- 7.2 KB